The Benefits of Having a Role in Your DLBCL Treatment Decisions
https://vimeo.com/636470473 Diffuse large B-cell lymphoma (DLBCL) patients have a vital role in their treatment decisions. Expert Dr. Loretta Nastoupil shares advice for patients on how to advocate for their best…
Should DLBCL Treatment Begin Immediately?
https://vimeo.com/635610427 For a newly diagnosed diffuse large B-cell lymphoma (DLBCL) patient, should treatment begin right away? Expert Dr. Loretta Nastoupil discusses the optimal time to begin treatment and how it…
How Does Biomarker Testing Impact DLBCL Treatment Options?
https://vimeo.com/635610213 Biomarker test results may help guide diffuse large B-cell lymphoma (DLBCL) treatment options. Expert Dr. Loretta Nastoupil explains how biomarkers are currently used in determining an optimal treatment approach…
What Are the Stages of DLBCL?
https://vimeo.com/635609828 Diffuse large B-cell lymphoma (DLBCL) care involves the use of a specific staging system. Expert Dr. Loretta Nastoupil shares insight about the DLBCL staging system and explains what is…
MPN Research and Optimism About Curative Therapies
https://vimeo.com/636610046 Myeloproliferative neoplasm (MPN) researcher Dr. John Mascarenhas discusses why he’s excited about the future of care for patients with essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF). Dr….
What To Expect When Starting MPN Inhibitor Therapy
https://vimeo.com/636610428 Changing a treatment approach for your essential thrombocythemia (ET), polycythemia vera (PV), or myelofibrosis (MF) can be intimidating. Dr. John Mascarenhas, a myeloproliferative neoplasm (MPN) specialist, shares tips and…
An Overview of ET, PV and MF Treatment Options
https://vimeo.com/636611502 Treatment for essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF) can vary greatly. Dr. John Mascarenhas breaks down the treatment types and the goals of treatment for each…
What Are the Benefits of MPN Inhibitor Treatment?
https://vimeo.com/636612929 MPN expert Dr. John Mascarenhas shares an overview of how inhibitor therapy works to treat myelofibrosis (MF) and the benefits of this type of treatment. Dr. John Mascarenhas is…
How Do MPNs Progress From One Disease to the Next?
https://vimeo.com/636617282 Understanding how essential thrombocythemia (ET), polycythemia vera (PV), or myelofibrosis (MF) are connected may be confusing to patients. Dr. John Mascarenhas, an expert in myeloproliferative neoplasms (MPNs), provides an…
Patient Considerations That Impact MPN Treatment Decisions
https://vimeo.com/636613669 How can personal choices play a role in your MPN care? Dr. John Mascarenhas reviews factors that should be considered, including lifestyle and overall health, when choosing therapy for…
What Questions Should Patients Ask About MPN Test Results?
https://vimeo.com/636614596 What should you know about your MPN test results? Dr. Mascarenhas discusses how test results are used, including the importance of genetic mutations and risk stratification when analyzing results….
Which Tests Do You Need Following an MPN Diagnosis?
https://vimeo.com/636616350 After a diagnosis of essential thrombocythemia (ET), polycythemia vera (PV), or myelofibrosis (MF), what testing should take place? Dr. John Mascarenhas shares an overview of essential and in-depth testing…